MSD Animal Health
MSD Animal Health, a division of Merck & Co., develops and markets veterinary pharmaceuticals, vaccines, digital livestock monitoring (Allflex, SenseHub), and animal identification products across ruminants, poultry, aquaculture, and companion animals in ~150 markets.
- Company typePrivate
- Founded2000
- HeadquartersIstanbul
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What MSD Animal Health does
MSD Animal Health is the global animal health division of Merck & Co., Inc. (also known as MSD outside the United States), developing, manufacturing, and marketing veterinary pharmaceuticals, vaccines (biologicals), digital livestock intelligence products, and animal identification/traceability systems. Its portfolio spans four primary species segments: ruminants (cattle, beef and dairy), poultry, fish/aquaculture, and companion animals (dogs, cats). Core products include the Allflex Livestock Intelligence platform (animal identification, cow/group/herd tracking, heat detection at 95% accuracy), SenseHub monitoring systems (early disease detection via behavioral analysis), the Innovax poultry vaccine series (vector-based protection against Newcastle Disease, Infectious Bursal Disease, and Marek's Disease), EXZOLT (the first European product with an EMA/CVMP-approved "improves animal welfare" label for poultry red mite control), NOBIVAC rabies vaccines, and AQUI-S/Finquel for aquaculture sedation and anesthesia.
The business is built on proprietary platforms including SPHEREON freeze-drying technology for poultry vaccines, HVT vector/chimeric vaccine technology, Viral Flex-Seq NGS-based vaccine verification, and a continuous R&D pipeline bridging pharmaceuticals and biologicals. MSD Animal Health sells its products through a multi-channel go-to-market model: direct field sales teams organized by species business unit, established distributor networks (notably in Turkey via Intervet Veteriner İlaçları Pazarlama ve Ticaret Limited Şirketi, established May 2000), veterinary clinics, pet pharmacies, and authorized technology resellers for digital products. The portfolio reaches customers in approximately 150 markets across 50+ countries, with the parent company's 130+ years of pharmaceutical heritage providing brand, R&D, and manufacturing leverage. Revenue is generated through one-time product sales (vaccines, pharmaceuticals, hardware like ear tags and monitoring collars) plus professional services and technical support (training programs, advisory services, the Sağlık Çemberi/Health Circle platform).
MSD Animal Health firmographics
Firmographics- Name
- MSD Animal Health
- Legal name
- Intervet Veteriner İlaçları Pazarlama ve Ticaret Limited Şirketi
- Website
- https://msd-hayvan-sagligi.com
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- MSD Animal Health, a division of Merck & Co., develops and markets veterinary pharmaceuticals, vaccines, digital livestock monitoring (Allflex, SenseHub), and animal identification products across ruminants, poultry, aquaculture, and companion animals in ~150 markets.
- Ownership category
- akta.pro rank
MSD Animal Health industry classification
Industry- Product category
- Veterinary Pharmaceuticals and Animal Health Products
- NAICS
- Veterinary Services (54194)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), Agricultural Services (700)
- akta.pro primary industry
- Livestock & Production Animal Therapeutics (Rx) (HLAMAEAB)
- akta.pro secondary industries
- Livestock Vaccines (Cattle, Swine, Sheep & Goats) (HLAMAKAB), Veterinary Vaccines (Biologics) (HLAMAEAL), Food Animal (Bovine/Dairy/Beef) Veterinary Services (HLAMABAA)
Keywords
Where MSD Animal Health is headquartered
LocationHeadquarters
- HQ city
- Istanbul
Offices2 records
Markets served
MSD Animal Health business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Marketing or Sales, Personnel, Operations
Revenue model
- Veterinary Pharmaceuticals: Sale of pharmaceutical products for the treatment and prevention of diseases in livestock (ruminants, poultry, fish) and companion animals. Includes parasiticides, antibiotics, and other therapeutic products.
- Veterinary Vaccines (Biologicals): Development and sale of vaccines for poultry, ruminants, companion animals, and fish. Includes Innovax vaccine series, Nobivac rabies vaccines, and the SPHEREON freeze-dried vaccine technology.
- Health Management Solutions and Technical Services: Technical and marketing support services, training programs, and advisory services provided to veterinarians, farmers, and animal owners. Includes the Sağlık Çemberi (Health Circle) platform.
- Digital Identification and Monitoring Products: Sale of Allflex animal identification tags, SenseHub monitoring systems, and related digital livestock intelligence products for breeding tracking, health monitoring, and farm management.
- AQUI-S and Finquel (Fish Health): Sedative (AQUI-S) for salmon and rainbow trout used during treatment, pumping and transport; Finquel anesthetic for fish farms used during vaccination and fish counting procedures.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels6 records
MSD Animal Health product offering
Product offeringCore offering
MSD Animal Health develops, manufactures, and markets a broad portfolio of veterinary pharmaceuticals and biologicals (vaccines) for the prevention and treatment of diseases in livestock (ruminants, poultry, fish) and companion animals. Its offering extends to digital animal identification, traceability, and real-time behavior monitoring products (Allflex Livestock Intelligence, SenseHub) and bundled technical and advisory services for veterinarians and farmers.
Product overview
MSD Animal Health operates as a diversified animal health company offering veterinary pharmaceuticals, vaccines, health management solutions, and digital identification, traceability, and monitoring products. The product portfolio includes Allflex Livestock Intelligence for ruminant identification and tracking, SenseHub Dairy Youngstock for calf monitoring, the Innovax vaccine series for poultry, NOBIVAC rabies vaccines, EXZOLT for poultry red mite treatment, and AQUI-S/Finquel for fish sedation. The company also offers the Sağlık Çemberi (Health Circle) platform for cattle health management and the Altın Dokunuş (Golden Touch) program for egg producers. Following acquisitions of Antelliq (2019), Scan Aqua (2019), and Vilsan (2017), the portfolio expanded to include Sure Petcare (companion animals), Biomark (fish health), and broad ruminant pharmaceuticals. Products are sold in approximately 150 markets across more than 50 countries.
Differentiator
Problem solved
Functional benefit
Brands
- Allflex Livestock Intelligence: Livestock intelligence solutions including animal identification, individual cow, group and herd tracking, farm/business management solutions using smart, actionable management information.
- Sure Petcare
- Biomark
- Vaki
- MSD Animal Health Technologies
- Sağlık Çemberi
- Altın Dokunuş
Products and services
- Allflex Livestock Intelligence Digital livestock identification and monitoring solution providing real-time data on rumination, breeding cycles, health indicators, and group/herd management through ear tags and neck collars for dairy and beef operations.
- SenseHub Dairy Youngstock Monitoring system for calf health that tracks rumination, suckling, activity, and eating behaviors, alerting farmers to potential health issues in young calves before clinical signs appear.
- Innovax Aşı Serisi (Innovax-ND-IBD) Poultry vaccine series providing single-dose long-term protection against Newcastle Disease (ND), Infectious Bursal Disease (IBD), and Marek's Disease (MD), with verification available through the Viral Flex-Seq NGS tool.
- AQUI-S Sedative used for treatment, pumping, and transport of salmon and rainbow trout in aquaculture operations.
- Finquel Anesthetic used in fish farms during vaccination procedures and other operations requiring fish anesthesia.
- EXZOLT Poultry treatment for red mite (Dermaniphilus gallinae) infestations, approved by EMA/CVMP as the first product in Europe to carry 'improves animal welfare' labeling.
- NOBIVAC Aşı Serisi (Rabies Vaccines) Rabies vaccine series used in MSD Animal Health's Afya program, with over 3 million doses donated for rabies control efforts in endemic regions.
- Sure Petcare Companion animal health technology brand offering pet care products and services, supporting monitoring and welfare of dogs and cats.
- Biomark Fish health technology brand offering products and solutions for fish identification, monitoring, and management in aquaculture.
- Vaki Fish health products and solutions brand offering monitoring and management tools for aquaculture operations.
- Vilsan Veteriner İlaçları Ruminant-focused veterinary pharmaceutical product line with Turkey-based manufacturing capacity, integrated into MSD Animal Health's portfolio following the Vilsan acquisition.
- Altın Dokunuş (Golden Touch) Programı Technical services and marketing support program for egg (layer) producers combining advisory support with MSD's vaccine and layer management offerings.
Quantifiable outcome
- EXZOLT reduces chicken nighttime activity, head scratching, pecking, feather pecking behaviors, and lowers blood corticosterone levels in hens with red mite infestations, as confirmed by EMA/CVMP field studies
- +4 more outcomes
Companies that use MSD Animal Health
Customer profileNamed customers1 record
Segments5 records
Ideal customer profiles4 records
MSD Animal Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature7 records
MSD Animal Health partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- Antelliq (Allflex Livestock Intelligence, Sure Petcare, Biomark)coreAcquisition of Antelliq, a global leader in digital livestock monitoring, identification, and tracking technology. Brought Allflex Livestock Intelligence, Sure Petcare (companion animal tech), and Biomark (fish health) into MSD Animal Health's portfolio. Established MSD Animal Health Technologies as a new operating unit in 2020.
- Scan Aqua AS (Scanvacc AS subsidiary)minorAcquisition of Norway-based fish health company specializing in aquaculture health products including AQUI-S sedative and Finquel anesthetic for salmon and trout. Strengthened MSD Animal Health's fish health portfolio and presence in Norwegian aquaculture markets.
- Vilsan Veteriner İlaçları Sanayi ve Ticaret A.Ş. (Vimar Grubu)coreAcquisition of Turkey's largest private sector animal health product manufacturer, strengthening MSD Animal Health's local manufacturing capacity, product portfolio (especially ruminant pharmaceuticals), and market presence in Turkey and export markets. Vilsan's CEO Burhan Hacı joined MSD Animal Health Turkey as General Manager. Turkey's livestock sector is one of Europe's most important, ranking second in population.
- Afya Serengeti ProjectcoreLong-term research partnership (initiated 1996) involving MSD Animal Health, Afya Project, and the University of Glasgow to study rabies transmission and elimination through domestic dog vaccination in the Serengeti region. Research has demonstrated that vaccinating at least 70% of domestic dogs can eliminate rabies and protect wildlife, domestic animals, and local communities.
- Mission RabiescoreLong-term strategic partnership with Mission Rabies organization to combat rabies globally through mass vaccination programs, awareness campaigns, and field operations in endemic regions. MSD Animal Health has donated over 3 million rabies vaccine doses through its Afya Program. The partnership supports the WHO goal of 'Zero Human Rabies Deaths by 2030'.
- Rabies Free AfricacorePartnership with Rabies Free Africa to eliminate rabies in Africa through mass dog vaccination programs, research, and community education. Works in conjunction with Mission Rabies under the Afya Program umbrella.
- Global Universities and Research InstitutesminorOngoing collaborations with universities, biotechnology companies, and research institutes alongside internal R&D, including joint research with MSD Human Health teams. Also collaborates with Nebraska University's Great Plains Education Center for bovine health content.
Scale indicators5 records
Recent moves7 records
Expansion highlights6 records
MSD Animal Health competitors and assessment
Company assessmentDirect peers
- Virbac: Independent global animal health company focused on companion animal parasiticides, vaccines, and livestock products. Directly competes with MSD in companion animal parasiticide markets and livestock vaccines.
- Elanco Animal Health: One of the largest pure-play animal health companies following its Bayer Animal Health acquisition, offering companion animal, livestock, and poultry products. Heads-to-head competitor with MSD across parasiticides, vaccines, and nutritional health.
- Vetoquinol: Independent global animal health company operating in livestock and companion animal pharmaceuticals. Directly competes in cattle, swine, and companion animal therapeutics with overlap to MSD's portfolio.
- Phibro Animal Health: Global animal health and nutrition company with a meaningful livestock vaccines, parasiticides, and nutritional specialties portfolio. Direct competitor to MSD in ruminant and aquaculture health additives.
- Ceva Santé Animale: Global veterinary pharmaceutical and vaccine company with strength in poultry, swine, ruminant vaccines and reproduction products. Directly competes with MSD's poultry (Innovax) and ruminant portfolios across multiple regions.
- Zoetis: Global leader in animal health pharmaceuticals, vaccines, diagnostics, and genetic tests across companion and livestock species. Directly competes with MSD Animal Health across the same pharma/vaccine categories and species business units, and is the largest pure-play benchmark.
- Dechra Pharmaceuticals: Specialty animal health company focused on veterinary endocrinology, dermatology, and critical care pharmaceuticals for companion animals, plus a small livestock portfolio. Direct competitor in companion animal therapeutic categories.
- Boehringer Ingelheim Animal Health: Major animal health division within Boehringer Ingelheim, offering vaccines and pharmaceuticals for livestock and companion animals. Direct competitor in poultry vaccines (Inovaxrange, VAXXITEK) and swine vaccines, overlapping with MSD Animal Health in poultry and swine markets.
Broad incumbents
- IDEXX Laboratories: Global leader in veterinary diagnostics (in-clinic analyzers, reference lab testing) and software for companion and livestock animal practices. Broader incumbent serving overlapping veterinarian customers but focused on diagnostics rather than therapeutics.
Emerging players
- Bimeda: Global multi-species animal health company providing pharmaceuticals, vaccines, and nutritional products, with notable strength in livestock markets. Comparable in scope though smaller in scale than MSD's broader global platform.
Market position
Strengths5 records
Weaknesses5 records
Key risks6 records
Key highlights7 records
Customer concentration
MSD Animal Health social profiles
Digital presenceMSD Animal Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
MSD Animal Health leadership team
Management profileNumber of profiles
Profiles9 records
MSD Animal Health subsidiaries and ownership
Company hierarchySubsidiaries7 records
MSD Animal Health funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MSD Animal Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MSD Animal Health
What does MSD Animal Health do?
MSD Animal Health develops, manufactures, and markets a broad portfolio of veterinary pharmaceuticals and biologicals (vaccines) for the prevention and treatment of diseases in livestock (ruminants, poultry, fish) and companion animals. Its offering extends to digital animal identification, traceability, and real-time behavior monitoring products (Allflex Livestock Intelligence, SenseHub) and bundled technical and advisory services for veterinarians and farmers.
Is MSD Animal Health a public or private company?
MSD Animal Health is a private company. It is classified as corporate owned and is currently operating.
When was MSD Animal Health founded?
MSD Animal Health was founded in 2000. It employs 251 to 500 people.
Where is MSD Animal Health based?
MSD Animal Health is headquartered in Istanbul.
How does MSD Animal Health make money?
Five revenue lines are on record. Veterinary Pharmaceuticals are the primary driver. The others are veterinary Vaccines (Biologicals), health Management Solutions and Technical Services, digital Identification and Monitoring Products and AQUI-S and Finquel (Fish Health).
Who are MSD Animal Health's main competitors?
Direct peers on record are Virbac, Elanco Animal Health, Vetoquinol, Phibro Animal Health, Ceva Santé Animale, Zoetis, Dechra Pharmaceuticals and Boehringer Ingelheim Animal Health. IDEXX Laboratories is listed as a broad incumbent. Bimeda is listed as an emerging player.
Does MSD Animal Health have an API?
No public API is recorded for MSD Animal Health.
What industry is MSD Animal Health in?
MSD Animal Health's product category is Veterinary Pharmaceuticals and Animal Health Products. Its primary akta.pro industry code is HLAMAEAB, Livestock & Production Animal Therapeutics (Rx), with a secondary code of HLAMAKAB, Livestock Vaccines (Cattle, Swine, Sheep & Goats). Its NAICS code is 54194 and its SIC code is 2836.